Ads
related to: glaxosmithkline products- TUKYSA® (tucatinib)
Treatment Option
FDA Approved
- Patient Brochure
Learn about TUKYSA®
Explore More Here
- Important Safety Info
View Safety Information
For TUKYSA® (tucatinib) tablets
- Explore FAQs Here
TUKYSA® (tucatinib) tablets
Frequently Asked Questions
- What is TUKYSA®?
Benefits of Treatment
Learn More Here Today
- Patient Resources
Read About TUKYSA®
Download Brochure & More
- TUKYSA® (tucatinib)
Search results
Healthy Returns: Drugmakers are capping inhaler prices at $35 in a win for some patients
CNBC· 2 days agoInhalers will soon get a whole lot cheaper for some Americans. Three of the world's largest inhaler...
Experts say Medicaid rebate change is behind inhaler price cuts - Roll Call
CQ Politics· 2 days agoThree of the four major inhaler manufacturers have announced plans to cap patient copays for all...
Medicaid change sparks warning for children
Newsweek· 2 days agoA switch in Medicaid's formula could mean many children will go without inhalers in the coming months. The process change means drugmakers have to pay...
12 Best Biotech Penny Stocks to Invest In
Insider Monkey via Yahoo Finance· 4 days agoIn this article, we discuss the 12 best biotech penny stocks to invest in. If you want to skip our detailed analysis of these stocks, go directly to 5...
These Inhalers No Longer Cost More Than $35 Per Month
Verywell Health via Yahoo News· 2 days agoGSK GSK announced its $35 out-of-pocket price cap on March 20, though it’s not the first example of...
Senators Have Pushed Big Pharma to Cap Inhaler Prices at $35–Bringing Relief to American Families
GoodNewsNetwork· 3 days agoInhalers have been available since the 1950s, and most of the drugs they use have been on the market...
CT-based Boehringer Ingelheim to cap out-of-pocket inhaler costs at $35
Stamford Advocate· 6 days agoSenate committee launched an investigation of the Ridgefield-based company and several other...
32 Countries with the Highest Rates of Diabetes
Insider Monkey via Yahoo Finance· 3 days agoIn this article, we will be taking a look at the 32 countries with the highest rates of diabetes. If you do not want to learn about the global diabetes...
Small Business - Cordele Dispatch | Cordele Dispatch
Cordele Dispatch· 4 days agoJersey City, NJ, March 25, 2024 (GLOBE NEWSWIRE) -- Global Ocular Inflammation Treatment Market is valued at US$ 428.7 Mn in 2023, and it is expected to reach US$ 690.4 Mn by 2031, with a CAGR of 6.31% during the forecast period of 2024-2031